These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 75603)

  • 1. [Use of progesterone in prostatic adenoma].
    Shcherbakov AP
    Urol Nefrol (Mosk); 1978; (1):72-6. PubMed ID: 75603
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progesterone drugs and adenoma of the prostate. Considerations on a 4-year trial].
    Steckelmacher P
    Acta Urol Belg; 1973 Jul; 41(3):462-4. PubMed ID: 4127420
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of therapy with progesterone in micturition disturbances due to prostatic hypertrophy].
    Cucinotta D; Passeri M
    Minerva Med; 1972 Apr; 63(27):1583-600. PubMed ID: 4112960
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences in the treatment of prostatic hypertrophy with high doses of progesterone administered rectally].
    Marini A; Cavalca GG
    Minerva Urol; 1974; 26(3):140-5. PubMed ID: 4138638
    [No Abstract]   [Full Text] [Related]  

  • 5. Gestronol hexanoate (SH582) and benign prostatic hypertrophy.
    Pitchford AG
    Proc R Soc Med; 1972 Feb; 65(2):128-9. PubMed ID: 4117436
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of treating prostatic adenoma with Depostat].
    Darenkov AF; Zakhvatov IuM; Tanko A; Ignashin NS; Varentsov GI
    Urol Nefrol (Mosk); 1980; (5):34-7. PubMed ID: 6158780
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current possibilities in the treatment of prostatic adenoma].
    Grims P; Bemarić R
    Lijec Vjesn; 1974 Dec; 96(12):B786-9. PubMed ID: 4142059
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of 17-alpha-hydroxy-19-norprogesterone acaproate (SH-582) on prostatic hypertrophy with special reference to estimation of size of the prostate by means of ultrasonotomography].
    Watanabe H; Kaiho H; Takahashi H; Kato T; Shima M
    Hinyokika Kiyo; 1970 Sep; 16(9):438-45. PubMed ID: 4097357
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of prostatic hypertrophy with progestational steroid (gestonorone caproate)].
    Tanaka H; Fukushige M; Shiraishi T
    Hinyokika Kiyo; 1970 Sep; 16(9):531-50. PubMed ID: 4097365
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of prostatic hypertrophy with 19-norhydroxyprogesterone caproate].
    Kato T; Okada K
    Hinyokika Kiyo; 1970 Sep; 16(9):489-500. PubMed ID: 4097361
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of 17-alpha-norhydroxy-progesterone caproate (SH 582) in treatment of prostatic hypertrophy].
    Hara S; Suemitsu H; Matsuda G; Fukuhara I; Shiba T
    Hinyokika Kiyo; 1970 Sep; 16(9):501-7. PubMed ID: 4097362
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of gestagens on the symptoms of prostatic hypertrophy].
    Graber P; Leibundgut B
    Urologe A; 1972 Nov; 11(6):326-9. PubMed ID: 4118967
    [No Abstract]   [Full Text] [Related]  

  • 13. Benign hyperplasia of the human prostate exposed to steroid hormones in organ culture.
    Harbitz TB; Falkanger B; Sander S
    Acta Pathol Microbiol Scand Suppl; 1974; Suppl 248():89-93. PubMed ID: 4141577
    [No Abstract]   [Full Text] [Related]  

  • 14. 5 Alpha-dihydrotestosterone-induced changes in the rat prostate.
    McGuire L; Bariso CD; Van Petten LE; Washington CL; DaVanzo JP; Willigan DA
    Invest Urol; 1973 Sep; 11(2):101-5. PubMed ID: 4125579
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of prazosin on human prostatic adenoma tissue].
    Kaminka ME; Zhirnikova ML; Vinarov AZ; Mashkovskiĭ MD; Pytel' IuA
    Biull Eksp Biol Med; 1988 Aug; 106(8):187-8. PubMed ID: 2458142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progestogen therapy for prostatic hypertrophy].
    Tabayashi Y; Kawabata T; Sasaki H
    Hinyokika Kiyo; 1970 Sep; 16(9):459-72. PubMed ID: 4097964
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological options in the treatment of benign prostatic hyperplasia.
    Kenny B; Ballard S; Blagg J; Fox D
    J Med Chem; 1997 Apr; 40(9):1293-315. PubMed ID: 9135028
    [No Abstract]   [Full Text] [Related]  

  • 18. [A study of cefoperazone prostatic tissue levels: difference between the gland and capsule].
    Fukushima S; Miura T; Kondo I; Fujii H; Hirokawa M; Iwasaki A; Ishizuka E; Kitajima N
    Hinyokika Kiyo; 1983 Jan; 29(1):87-93. PubMed ID: 6203376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Astromicin sulfate concentration in human prostatic tissue after an intramuscular injection].
    Morita M; Hasuda A
    Hinyokika Kiyo; 1988 Oct; 34(10):1865-8. PubMed ID: 2469325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ofloxacin concentration in prostatic tissue].
    Kawauchi A; Kamoi K; Ohne T; Imada N; Kitamori T; Terasaki T; Watanabe H
    Hinyokika Kiyo; 1993 Dec; 39(12):1191-3. PubMed ID: 7506868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.